Trial
NCT06522035
Evaluation of Allocetra by Intra-articular Injection for the Treatment of Psoriatic Arthritis
Phase ITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Enlivex Therapeutics Ltd.
Collaborators
—
Condition
Arthritis, Psoriatic
Intervention
Allocetra
Why stopped
reprioritization
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2026-04-13